Prevalence of office and ambulatory hypotension in treated hypertensive patients with coronary disease.


Journal

Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690

Informations de publication

Date de publication:
07 2020
Historique:
received: 06 11 2018
accepted: 17 06 2019
revised: 08 06 2019
pubmed: 14 5 2020
medline: 18 8 2021
entrez: 14 5 2020
Statut: ppublish

Résumé

Patients with coronary heart disease (CHD) can be particularly susceptible to the adverse effects of excessive blood pressure (BP) lowering by antihypertensive treatment. The identification of hypotension is thus especially important. This study estimated the prevalence of hypotension among CHD-treated hypertensive patients undergoing ambulatory blood pressure monitoring (ABPM) in routine clinical practice. We performed a cross-sectional study with 2892 CHD-treated hypertensive patients from the Spanish ABPM Registry. Based on previous studies, hypotension was defined as systolic/diastolic BP < 120 and/or 70 mmHg according to office measurements, <115 and/or 65 mmHg according to daytime ABPM, <100 and/or 50 mmHg according to nighttime ABPM, and <110 and/or 60 mmHg according to 24 h ABPM. The participants' mean age was 67.1 years (69.8% men). A total of 19.6% of the patients had office hypotension, 26.5% had daytime hypotension, 9.0% had nighttime hypotension, and 16.1% had 24-hr ABPM hypotension. Low diastolic BP values were responsible for most cases of hypotension. Fifty-eight percent of the cases of hypotension detected by daytime ABPM did not correspond to hypotension according to office BP. The variables independently associated with daytime ambulatory systolic/diastolic hypotension and diastolic hypotension (the latter being the most frequent type of ambulatory hypotension) were age, female sex, and the number of antihypertensive medications. In conclusion, in a large ABPM registry, one out of every four CHD-treated hypertensive patients was potentially at risk because of hypotension according to daytime ABPM, and more than half of them were not identified if office BP was relied on alone. We suggest that ABPM should be performed in these patients.

Identifiants

pubmed: 32398795
doi: 10.1038/s41440-020-0462-9
pii: 10.1038/s41440-020-0462-9
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

696-704

Références

Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor cluster in 21 regions 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2224–60.
pubmed: 23245609 pmcid: 4156511 doi: 10.1016/S0140-6736(12)61766-8
Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risk, healthy life-years lost and age specific associations in 1.25 million people. Lancet. 2014;383:1899–911.
pubmed: 24881994 pmcid: 4042017 doi: 10.1016/S0140-6736(14)60685-1
Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk-overview and meta-analyses of randomized trials. J Hypertens. 2014;32:2305–14.
pubmed: 25259548 doi: 10.1097/HJH.0000000000000380
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.
pubmed: 23771844 doi: 10.1093/eurheartj/eht151
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.
doi: 10.1001/jama.2013.284427 pubmed: 24352797
Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs less intensive blood pressure lowering and different achieved blood pressure levels-update overview and meta-analyses of randomized trials. J Hypertens. 2016;34:613–22.
pubmed: 26848994 doi: 10.1097/HJH.0000000000000881
Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67.
pubmed: 26724178 doi: 10.1016/S0140-6736(15)01225-8
Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, et al. Treatment of hypertension in patients with coronary artery disease. A scientific statement from the American Heart Association, American College of Cardiology and American Society of Hypertension. Hypertension. 2015;65:1372–407.
pubmed: 25828847 doi: 10.1161/HYP.0000000000000018
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:2199–269.
pubmed: 29146533 doi: 10.1016/j.jacc.2017.11.005
Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003;290:2805–16.
pubmed: 14657064 doi: 10.1001/jama.290.21.2805
Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP, PROVE IT-TIMI 22 trial investigators. What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy. Thrombolysis In Miocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010;122:2142–51.
pubmed: 21060068 doi: 10.1161/CIRCULATIONAHA.109.905687
Owens P, O´Brien E. Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Heart. 1999;82:477–81.
pubmed: 10490564 pmcid: 1760270 doi: 10.1136/hrt.82.4.477
Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388:2142–52.
pubmed: 27590221 doi: 10.1016/S0140-6736(16)31326-5
Ruilope LM, Segura J, Zamorano JL. New clinical concepts after the ONTARGET trial. Expert Rev Cardiovasc Ther. 2011;9:685–9.
pubmed: 21714599 doi: 10.1586/erc.11.52
Divisón-Garrote JA, Banegas JR, De la Cruz JJ, Escobar-Cervantes C, De la Sierra A, Gorostidi M, et al. Hypotension based on office and ambulatory monitoring blood pressure. Prevalence and clinical profile among a cohort of 70.997 treated hypertensives. J Am Soc Hypertens. 2016;10:714–23.
pubmed: 27451950 doi: 10.1016/j.jash.2016.06.035
Wright JT,Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, SPRINT Research Group, et al. A randomized trial of intensive versus standard blood pressure control. N Engl J Med. 2015;373:2103–16.
pubmed: 26551272 doi: 10.1056/NEJMoa1511939
Banegas JR, Segura J, Sobrino J, Rodríguez-Artalejo F, de la Sierra A, de la Cruz JJ, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49:62–68.
pubmed: 17075026 doi: 10.1161/01.HYP.0000250557.63490.55
De la Sierra A, Banegas JR, Segura J, Gorostidi M, Ruilope LM, CARDIORISC Event Investigators. Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study. J Hypertens. 2012;30:713–9.
pubmed: 22306850 doi: 10.1097/HJH.0b013e328350bb40
Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Clinic versus daytime ambulatory blood pressure differences among hypertensive patients. The impact of age on clinic blood pressure. Hypertension. 2017;69:211–9.
pubmed: 28028191 doi: 10.1161/HYPERTENSIONAHA.116.08567
Banegas JR, de la Sierra A, Segura J, Gorostidi M, de la Cruz J, Rodríguez-Artalejo F, et al. Control of hypertension in coronary heart disease. Int J Cardiol. 2009;134:245–7.
pubmed: 18353471 doi: 10.1016/j.ijcard.2007.12.073
Mak G, Murphy NF, Ali A, Walsh A, O’Loughlin C, Conlon C, et al. Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much? J Card Fail. 2008;14:555–60.
pubmed: 18722320 doi: 10.1016/j.cardfail.2008.03.003
Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, ONTARGET Investigators, et al. Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547–59.
pubmed: 18378520 doi: 10.1056/NEJMoa0801317
Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, ADVANCE Collaborative Group, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829–40.
pubmed: 17765963 doi: 10.1016/S0140-6736(07)61303-8
Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–28.
pubmed: 19052124 doi: 10.1056/NEJMoa0806182
Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension exactly how essential? J Am Coll Cardiol. 2009;54:1827–34.
pubmed: 19892233 doi: 10.1016/j.jacc.2009.05.073
Rabkin SW, Waheed A, Poulter RS, Wood D. Myocardial perfusion pressure in patients with hypertension and coronary disease: implications for DBP targets in hypertension management. J Hypertens. 2013;31:975–82.
pubmed: 23511338 doi: 10.1097/HJH.0b013e32835e831c
Owens PE, Lyons SP, O´Brien ET. Arterial hypotension: prevalence of low blood pressure in the general population using ambulatory blood pressure monitoring. J Hum Hypertens. 2000;14:243–7.
pubmed: 10805049 doi: 10.1038/sj.jhh.1000973
Scuteri A, Modestino A, Frattari A, Di Daniele N, Tesauro M. Occurrence of hypotension in older participants. Which 24-hour ABPM parameter better correlate with? J Gerontol. 2012;67:867–74.
doi: 10.1093/gerona/glr232
Matsushita K, Harada K, Miyazaki T, Miyamoto T, Kohsaka S, Iida K, et al. Effect of heart failure secondary to ischemic cardiomyopathy on body weight and blood pressure. Am J Cardiol. 2017;120:1589–94.
pubmed: 28843394 doi: 10.1016/j.amjcard.2017.07.054
Lee SE, Lee HY, Cho HJ, Choe WS, Kim H, Choi JO, et al. Reverse J-curve relationship between on-treatment blood pressure and mortality in patients with heart failure. J Am Coll Cardiol Heart Fail. 2017;5:810–9.
Yannoutsos A, Ahouah M, Dreyfuss Tubiana C, Topouchian J, Safar ME, Blacher J. Aortic stiffness improves the prediction of both diagnosis and severity of coronary artery disease. Hypertens Res. 2018;41:118–25.
pubmed: 29118329 doi: 10.1038/hr.2017.97
Hashimoto J, Ito S. Central diastolic pressure decay mediates the relationship between aortic stiffness and myocardial viability: potential implications for aortosclerosis-induced myocardial ischemia. J Hypertens. 2017;35:2034–343.
pubmed: 28614093 doi: 10.1097/HJH.0000000000001436
Franklin SS, Gokhale SS, Chow VH, Larson MG, Levy D, Vasan RS, et al. Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham heart study. Hypertension. 2015;65:299–305.
pubmed: 25421982 doi: 10.1161/HYPERTENSIONAHA.114.04581
Ungar A, Pepe G, Lambertucci L, Fedeli A, Monami M, Mannucci E, et al. Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension. J Am Geriatr Soc. 2009;57:291–6.
pubmed: 19207144 doi: 10.1111/j.1532-5415.2008.02123.x
Vidal-Petiot E, Greenlaw N, Ford I, Ferrari R, Fox KM, Tardif JC, et al. Relationships between components of blood pressure and cardiovascular events in patients with stable coronary artery disease and hypertension. Hypertension. 2018;71:168–76.
doi: 10.1161/HYPERTENSIONAHA.117.10204 pubmed: 29084876
Benetos A, Labat C, Rossignol P, Fay R, Rolland Y, Valbusa F, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents. The PARTAGE study. JAMA Intern Med. 2015;175:989–95.
pubmed: 25685919 doi: 10.1001/jamainternmed.2014.8012
Gomadam P, Shah A, Qureshi W, Yeboah PN, Freedman BI, Bowden D, et al. Blood pressure indices and cardiovascular disease mortality in persons with or without diabetes mellitus. J Hypertens. 2018;36:85–92.
pubmed: 28800042 doi: 10.1097/HJH.0000000000001509
Shiue I. Increased health service use for hypotension in the very old: Northumbriam hospital episode statistics, 2013–2014. Int J Cardiol. 2015;201:185–7.
pubmed: 26298376 doi: 10.1016/j.ijcard.2015.08.023
Ricci F, Manzoli L, Sutton R, Melander O, Flacco ME, Gallina S, et al. Hospital admissions for orthostatic hypotension and syncope in later life: insights from the Malmo Preventive Project. J Hypertens. 2017;35:776–83.
pubmed: 28009704 doi: 10.1097/HJH.0000000000001215
Bress AP, Kramer H, Khatib R, Beddhu S, Cheung AK, Hess R, et al. Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the United States. Circulation. 2017;135:1617–28.
pubmed: 28193605 pmcid: 5404971 doi: 10.1161/CIRCULATIONAHA.116.025322
Banegas JR, Ruilope LM, Sierra A, Vinyoles E, Gorostidi M, Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378:1509–20.
pubmed: 29669232 doi: 10.1056/NEJMoa1712231
Verdecchia P, Reboldi G, Angeli F, Trimarco B, Mancia G, Pogue J, et al. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease. Hypertension. 2015;65:108–14.
pubmed: 25331850 doi: 10.1161/HYPERTENSIONAHA.114.04310
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC Scientific Document Group; 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.
pubmed: 30165516 pmcid: 30165516 doi: 10.1093/eurheartj/ehy339
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Task Force Members, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949–3003.
pubmed: 23996286 doi: 10.1093/eurheartj/eht310.P4876

Auteurs

Juan A Divisón-Garrote (JA)

Casas Ibáñez, Primary Care Center, Albacete, Spain.
Department of Medicine, Universidad Católica San Antonio, Murcia, Spain.

Juan J de la Cruz (JJ)

Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid, IdiPAZ and CIBERESP, Madrid, Spain.

Alejandro de la Sierra (A)

Department of Internal Medicine, Hospital Mutua Terrassa, Universidad de Barcelona, Barcelona, Spain.

Ernest Vinyoles (E)

La Mina Primary Care Center, Universidad de Barcelona, Barcelona, Spain.

Manuel Gorostidi (M)

Nephrology Department, Hospital Universitario Central de Asturias, RedinRed, Oviedo, Spain.

Carlos Escobar-Cervantes (C)

Department of Cardiology, Hospital Universitario La Paz, Madrid, Spain.

Julián Segura (J)

Hypertension Unit, Nephrology Department, Hospital Doce de Octubre, Madrid, Spain.

Vivencio Barrios (V)

Cardiology Department, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.

Luis M Ruilope (LM)

School of Doctoral Studies and Research, Instituto de Investigación Hospital Doce de Octubre, Universidad Europea de Madrid, Madrid, Spain.

José R Banegas (JR)

Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid, IdiPAZ and CIBERESP, Madrid, Spain. joseramon.banegas@uam.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH